Gerson Lehrman Group - Intelligently Connecting Institutions and Expertise.

Study Group: Ophthalmologists

Council Members in this Study Group: 1610

This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.

Contact Gerson Lehrman Group to survey or consult with members of this Study Group

Leading institutions connect with members of this Study Group through GLG

Leading Experts in this Study Group

Sanjay Rao, MD, Medical Director, Lakeside Eye ClinicSanjay Rao, MD

Medical Director
Lakeside Eye Clinic
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Sanjay Rao, MD, is the Medical Director and Director of Cornea and Refractive Surgery at the Lakeside Eye Clinic in Chicago. He was previously the Director of Cornea and Refractive Surgery at the University of Chicago. He has clinical expertise in diseases of the cornea and is a high volume cataract,...

34 recent news post(s)
2 recent event(s)
Jeffrey Marx, MD, Chairman of the Department of Ophthalmology , LAHEY CLINIC, INC.Jeffrey Marx, MD

Chairman of the Department of Ophthalmology
LAHEY CLINIC, INC.
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Jeffrey Marx, MD, is a Chairman of the Department of Ophthalmology at the Lahey Clinic in Burlington and Associate Clinical Professor of Ophthalmology at Tufts University School of Medicine, Massachusetts. Dr Marx specializes in medical and surgical diseases of the retina including diabetic eye care,...

Gaurav Shah, MD, Associate Professor of Ophthalmology, WASHINGTON UNIVERSITY MEDICAL CENTERGaurav Shah, MD

Associate Professor of Ophthalmology
WASHINGTON UNIVERSITY MEDICAL CENTER
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Gaurav Shah, MD, is an Associate Professor of Ophthalmology at the Washington University Medical Center in Missouri. He is a national expert in the care of patients with diabetic retinopathy/diabetic macular edema, age-related macular degeneration, retinal detachments, and the economics of retinalhealth...

3 recent news post(s)
Barry Schechter, MD, Director of Corneal and External Diseases, FLORIDA EYE MICROSURGICAL INSTITUTE INCBarry Schechter, MD

Director of Corneal and External Diseases
FLORIDA EYE MICROSURGICAL INSTITUTE INC
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Barry Schechter, MD, is the Director of Department of Cornea and External Disease at Florida Eye Microsurgical Institute. Dr. Schechter's practice involves diseases of the ocular surface including dry eyes, allergies, infection; the latest in corneal, refractive, and cataract surgery, and glaucoma....

5 recent news post(s)
Elizabeth Davis, MD, FACS, Partner, MINNESOTA EYE CONSULTANTS PAElizabeth Davis, MD, FACS

Partner
MINNESOTA EYE CONSULTANTS PA
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Elizabeth Davis, MD, FACS, is Clinical Assistant Professor of Ophthalmology at the University of Minnesota. Dr. Davis is also Partner and Medical Director of the Surgery Center at Minnesota Eye Consultants. She is fellowship trained in corneal, cataract, and refractive surgery. Dr. Davis is actively...

Andrew Dahl, MD

President
Ophthalmology Consultants
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Andrew Dahl, MD, FACS, FAAO, is the President of Ophthalmology Consultants in New York. He was also Principal Investigator for Hudson Valley Eye Research Foundation and has conducted numerous clinical trials. Dr. Dahl is a board-certified Ophthalmologist/Ophthalmic Surgeon. He has expertise in allaspects...

23 recent news post(s)
Paul Chen, MD, Ophthalmologist, North County Laser Eye AssociatesPaul Chen, MD

Ophthalmologist
North County Laser Eye Associates
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Paul Chen, MD, is an Ophthalmologist at North County Laser Eye Associates in San Diego County, California. He provides comprehensive eye care with a focus on cataracts, glaucoma, eyelid enhancements, and laser vision correction. Dr. Chen has expertise in the latest medical and surgical techniques such...

1 recent news post(s)
Mark Packer, MD, Clinical Associate Professor of Ophthalmology, OREGON HEALTH & SCIENCE UNIVERSITY - CCMark Packer, MD

Clinical Associate Professor of Ophthalmology
OREGON HEALTH & SCIENCE UNIVERSITY - CC
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Mark Packer, MD, FACS, is Clinical Associate Professor of Ophthalmology at Oregon Health & Sciences University. He is also in private practice with Drs. Fine and Hoffman in Eugene, OR. Dr. Packer's research focuses on refractive surgery, intraocular lens technology and glaucoma surgical devices. He...

25 recent news post(s)

View all Leading Experts in this Study Group

GLG NewsSM Analyses by this Study Group's Leading Experts (?)

Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.

Watershed Intraocular Lens: The Light Adjsutable Lens (Calhoun Vision)

November 19, 2009

GLG Expert Contributor

Pilot trial for toric correction with light-adjustable lens yields promising early results | ophthalmologytimes.modernmedicine.com

SInce years ophthalmologist await the approval of the LAL Light adjustable lens (calhoun VIsion) as it will represent a watershed in intraocular lens technology. 

Ozurdex (Allergan) Uses Billing Structure That May Prevent Acceptance

November 9, 2009

GLG Expert Contributor

Dexamethasone implant a first for macular edema after retinal vein occlusion | ophthalmologytimes.modernmedicine.com

Ozurdex (Allergan) is now on the market and available for ophthalmologists to treat patients with retinal vascular occlusions (RVO).While the technology and treatment may be sound, there may be significant hurdles to overcome from a billing standpoint.Ozurdex may follow the same fate as Lucentis (Genetech). ...

Lumigan X EU Committee Recomendation

October 27, 2009

Andrew Dahl, MD, President , Ophthalmology Consultants

EU committee backs marketing approval of Lumigan | www.pharmabiz.com

The Committee for Medicinal Products for Human Use (CHMP) of the European Union has recommended granting a Marketing Authorization for a new version of Allergan's Lumigan (bimatoprost ophthalmic solution). This new version will be marketed as Lumigan-X after approval. Lumigan X offers Allergan anew...

NO BRAINER: Genentech Prefers to Promote Lucentis over Avastin for Wet ARMD

October 7, 2009

GLG Expert Contributor

Genentech revisits plan for Avastin | www.sfgate.com

It does not require a lot of ophthalmic and business savy to understand why a company rather promote a drug that costs more than 20 times more to treat the same medical condition.

Tecnis Multifocal Outperforms Competitors

September 20, 2009

Mark Packer, MD, Clinical Associate Professor of Ophthalmology, OREGON HEALTH & SCIENCE UNIVERSITY - CC

Summary of Safety and Effectiveness Data (FDA) | www.fda.gov

The US Clinical Investigation of the Tecnis Multifocal demonstrated 88% complete freedom from glasses at 6 months, and 95% satisfaction at one year.  A comparable study of the ReStor lenses, with both 3 and 4 diopter adds, demonstrated 76% freedom from glasses at 4 - 6 months.  Despite a one line lower...

View All GLG News by members of this Study Group

Members in this Study Group include these company types:

  • Office Based Private Practice or Clinic
  • Academic Medical Center/Hospital or Clinic
  • Non-Academic Community Hospital or Clinic
  • Academic Institution*

Members in this Study Group often have these job titles:

  • Physician - Attending Physician
  • Owner
  • Physician - Director
  • President
  • Partner
  • Director

Related Study Groups

Study Group Name No. Members
Ophthalmologists (US) 1133
Corneal and Refractive Ophthalmic Surgeons (US) 518
Refractive Surgeons (US) 309
Ophthalmologists (EU) 318
Cornea Specialists (US) 224
Refractive Surgeons in Private Practice (US) 213
Physicians who Implant Intraocular Lenses 217

GLG Live Meetings with this Study Group's Leading Experts (?)

Upcoming Seminars

Leading Experts in Ophthalmologists Study Group have not participated in any upcoming seminars.

View All GLG Live Meetings in Healthcare

GLG Webcasts

Leading Experts in Ophthalmologists have not participated in any GLG webcasts.

View All GLG Webcasts in Healthcare